The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Sypmtoms in Adults
不断变化的 COVID-19 形势:捕捉瞬时居住环境暴露和成人哮喘症状的可行性研究
基本信息
- 批准号:10250681
- 负责人:
- 金额:$ 25.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-15 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdolescentAdultAdvocateAffectAirAir PollutantsAreaAsthmaBehaviorCOVID-19COVID-19 pandemicCOVID-19 preventionCellular PhoneChemical ExposureChemicalsChicagoChildChronicCommunicable DiseasesCommunitiesComplexComputer softwareCoronavirusDataData CollectionData ReportingDeath RateDiagnosisDirect CostsDisease OutbreaksDisinfectantsEcological momentary assessmentEconomic BurdenElderlyEnvironmental ExposureEnvironmental ImpactEnvironmental MonitoringEnvironmental Risk FactorExposure toFaceFacilities and Administrative CostsFeasibility StudiesFrequenciesFutureGoalsHandHomeHome environmentHourHouseholdHousingHygieneIndividualIndoor Air QualityIndoor environmentInterventionLung diseasesMeasuresMidwestern United StatesMonitorNotificationNursesParticipantParticulateParticulate MatterPatient Self-ReportPhysiciansPopulationPreventive measurePublic HealthPulmonary Function Test/Forced Expiratory Volume 1Quality-Adjusted Life YearsReadinessRecommendationReportingResearchRisk FactorsRisk ReductionScheduleScientistSelf ManagementShelter facilitySpirometrySurveysSymptomsTimeUnited StatesVirusVirus Diseasesage groupasthma exacerbationbasecostdesigneconomic impactenvironmental tobacco smokeexperiencefine particleshealth economicsimprovedinnovationmemberpandemic diseasepollutantpulmonary functionrecruitsensorusabilityvolatile organic compoundwillingness
项目摘要
ABSTRACT
The global pandemic of coronavirus 2019 (COVID-19) is a substantial cause for concern among individuals
with chronic respiratory diseases, including those with asthma. It is estimated that more than 60% of adults
with asthma have uncontrolled symptoms and this represents a substantial health and economic impact.
Compared to children, adults are nearly five times more likely to die from asthma and the asthma-related
death rate is highest among those 65 years and older. Viral infections are a prominent risk factor for
asthma exacerbation and, thus, SARS-CoV-2, the virus responsible for COVID-19, is cause for alarm among
those diagnosed with asthma. Sheltering-in-place orders and recommendations, physical distancing, wearing
face coverings, hand hygiene, and increased cleaning and disinfecting are primary COVID-19 preventative
measures advocated. The effects of home-based strategies to prevent COVID-19, specifically increased
residential exposure to cleaning/disinfecting agents and particulates on adults with asthma is unknown. Our
long term goal is to characterize the impact of COVID-19 on existing asthma risk factors so as to develop
tailored, home-based asthma interventions that adequately acknowledge COVID-19 and are responsive to the
changing home environment and home routines resulting from this pandemic. The aims of this study are: 1)
determine the feasibility and usability of: (a) ecological momentary assessment (EMA) to assess self-report
residential environmental exposures and asthma symptoms, (b) home monitoring of objective environmental
exposures (total volatile organic compounds [VOCs], particulates [PM2.5]), and lung function (home spirometry);
2a) assess the frequency and degree of residential environmental exposures (e.g., disinfectants/cleaners,
second-hand smoke) via (a) self-reported data, and (b) home monitoring objective measures, 2b) assess the
level of asthma control as indicated by self-reported asthma symptoms and lung function; and 3) explore
associations of self-reported and objective measures of residential environmental exposures with self-reported
and objective measures of asthma control. We will recruit 50 adults with asthma who completed our ongoing
online COVID-19 and asthma survey, indicated willingness to be contacted for future studies, reported high
use of disinfectant/cleaning products, and have not-well controlled asthma. Participants will receive an indoor
air quality monitor and a home spirometer to measure VOCs, PM2.5, and FEV1% respectively. EMA will be
collected using a personal smartphone and EMA software platform. Participants’ will be sent scheduled and
random EMA notifications to assess asthma symptoms, environmental exposures, lung function, and mitigation
strategies. After the 14-day data collection period, participants will respond to survey items related
acceptability, appropriateness, and feasibility. Findings from this feasibility study will support a powered study
to address the impact of environmental exposures related to COVID-19 and to enhance preparedness for
future infectious disease outbreaks by developing innovative intervention strategies for those with asthma.
抽象的
2019 年冠状病毒 (COVID-19) 的全球大流行是引起个人担忧的重要原因
据估计,超过 60% 的成年人患有慢性呼吸道疾病,包括哮喘。
哮喘患者的症状不受控制,这对健康和经济产生了重大影响。
与儿童相比,成人死于哮喘的可能性高出近五倍,而与哮喘相关的疾病
65 岁及以上人群的死亡率最高,病毒感染是一个重要的危险因素。
哮喘恶化,因此 SARS-CoV-2(导致 COVID-19 的病毒)引起了人们的警惕
被诊断患有哮喘的人 就地避难的命令和建议、保持身体距离、穿着。
面罩、手部卫生以及加强清洁和消毒是主要的 COVID-19 预防措施
提倡的居家策略的效果尤其显着增强。
患有哮喘的成人在住宅中接触清洁/消毒剂和颗粒物的情况尚不清楚。
长期目标是确定 COVID-19 对现有哮喘危险因素的影响,以便制定
量身定制的、以家庭为基础的哮喘干预措施,充分认识到 COVID-19 并响应
这次流行病导致的家庭环境和家庭日常生活的改变本研究的目的是:1)
确定以下方面的可行性和可用性: (a) 生态瞬时评估(EMA)以评估自我报告
居住环境暴露和哮喘症状,(b) 客观环境的家庭监测
暴露(总挥发性有机化合物 [VOC]、颗粒物 [PM2.5])和肺功能(家庭肺活量测定);
2a) 评估住宅环境暴露的频率和程度(例如消毒剂/清洁剂、
二手烟)通过 (a) 自我报告数据,以及 (b) 家庭监测客观措施,2b) 评估
自我报告的哮喘症状和肺功能表明哮喘控制水平;3) 探索
住宅环境暴露的自我报告和客观测量与自我报告的关联
我们将招募 50 名完成我们正在进行的哮喘治疗的成年人。
在线 COVID-19 和哮喘调查,表明愿意联系未来的研究,报告高
使用消毒剂/清洁产品且哮喘控制不佳的参与者将接受室内治疗。
空气质量监测仪和家用肺活量计分别测量 VOC、PM2.5 和 FEV1%。
使用个人智能手机和 EMA 软件平台收集的信息将按计划发送。
随机 EMA 通知评估哮喘症状、环境暴露、肺功能和缓解情况
在 14 天的数据收集期结束后,参与者将对相关的调查项目做出回应。
该可行性研究的可接受性、适当性和可行性将支持有力的研究。
解决与 COVID-19 相关的环境暴露的影响并加强应对准备
通过为哮喘患者制定创新的干预策略来应对未来传染病的爆发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kamal M Eldeirawi其他文献
Kamal M Eldeirawi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kamal M Eldeirawi', 18)}}的其他基金
The Changing COVID-19 Landscape: A Feasibility Study to Capture Momentary Residential Environmental Exposures and Asthma Sypmtoms in Adults
不断变化的 COVID-19 形势:捕捉瞬时居住环境暴露和成人哮喘症状的可行性研究
- 批准号:
10369705 - 财政年份:2021
- 资助金额:
$ 25.71万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Reducing Vaccine Hesitancy among Hispanic Parents of COVID-19 Vaccine-Eligible Children
减少有资格接种 COVID-19 疫苗的儿童的西班牙裔家长对疫苗的犹豫
- 批准号:
10737776 - 财政年份:2023
- 资助金额:
$ 25.71万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10568736 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10895221 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
- 批准号:
10708938 - 财政年份:2022
- 资助金额:
$ 25.71万 - 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:
10320491 - 财政年份:2021
- 资助金额:
$ 25.71万 - 项目类别: